ABSTRACT OBJECTIVES This study sought to determine mortality rates among cardiogenic shock (CGS) patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome in the contemporary treatment era and to determine predictors of mortality.
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RESULTS
The study flowchart is displayed in Figure 1 . An initial dataset consisting of 501,117 PCI procedures from all centers from the BCIS database in the United Kingdom were available for consideration. Of these, 6,489 patients were used as the patient observational group because they were recorded as having undergone PCI for ACS in the setting of CGS in England and
Wales and had complete 1-year mortality tracking. Figure 2 shows the incidence of shock over time. The baseline, angiographic, and procedural characteristics for all patients in this study cohort (N ¼ 6,489), those who died (group 1: n ¼ 2,872), and those who were alive at 1 year (group 2: n ¼ 3,617) are displayed in Tables 1 and 2 .
BASELINE CHARACTERISTICS. The baseline characteristics are displayed in Kunadian et al.
Cardiogenic Shock in the Contemporary Era Figure 3 . The Kaplan-Meier curve for mortality is displayed in Figure 4 . For patients with CGS, the 1-year mortality for patients who were known to be alive at 30 days was 11.1%. The 1-year mortality for ACS patients without CGS but with similar age-sex distribution as those of shock patients who were alive at 30 days was 5.7%.
PREDICTORS OF 30-DAY MORTALITY.
Multiple regression analysis was initially performed excluding procedure-related variables (artificial ventilation, IABP use, and radial procedure) and is displayed in Table 4) . 
PREDICTORS OF 1-YEAR MORTALITY.
Multiple regression analysis was initially performed excluding procedure-related variables (artificial ventilation, IABP use, and radial procedure) and is displayed in Values are mean AE SD or n/N (%).
CABG ¼ coronary artery bypass graft; CAD ¼ coronary artery disease; NSTEMI ¼ non-ST-segment elevation myocardial infarction; PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction; UA ¼ unstable angina. The size of the reported cohort allows us to describe important predictors of poor outcome in this condition. Thus, for example, age as might have been expected, was an independent predictor of mortality at 1 year in our study. This is consistent with other observational studies such as that from the GRACE (Global Registry of Acute Coronary Events) (10) and others demonstrating increased mortality with advanced age in ACS. In another small study of patients with CGS, 1 multiple predictor of in-hospital mortality was age $75 years (hazard ratio: 1.81, 95% CI: 1.006 to 3.27; p ¼ 0.04) (11) . Optimal treatment strategies for older patients presenting with CGS and undergoing PCI are not known and warrant further The graph shows 1-year mortality following percutaneous coronary intervention in cardiogenic shock. Tables 1 and 2 . hypothermia in our study are not available from the dataset. The question as to whether the use of therapeutic hypothermia in the setting of CGS, within or without the context of cardiac arrest, which could lead to improved survival is so far unknown, but our study highlights that this may be an area worthy of further study.
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Our study demonstrated that IABP use was an independent predictor of 1-year mortality. It is likely that IABP use is simply a marker of worse clinical state at presentation and the perception in operators' minds that it might be of value in such patients. The benefits of IABP use have recently been questioned.
In 1 study, the use of IABP did not significantly reduce 30-day mortality among patients with CGS complicating AMI in whom an early revascularization strategy was planned (15) . In another study, IABP was used only in one-quarter of patients with CGS treated Multiple logistic regressions including covariates artificial ventilation, radial procedure, and IABP use in the model. Total sample size ¼ 6,489, sample entered into MV model without missing data ¼ 2,783, total events ¼ 962. *Odds ratio (95% CI) and p values after applying multiple imputation NMAR (all 6,489 subjects were used; total events ¼ 2,422). †Case records with missing data. Tables 1 to 3 . Abbreviations as in Tables 1 to 3 .
Abbreviations as in
Cardiogenic Shock in the Contemporary Era STUDY LIMITATIONS. This is an observational study. However, it is mandatory for all institutions within the United Kingdom to submit their PCI to the national database, and the data are sufficiently robust to be used as a reference database and are publically available as an audit of outcome. The main strength is that our study represents all patients treated in
England and Wales in whom complete and Abbreviations as in Tables 1 to 3 . Of the data that was entered into the MV regression model, there were missing values as shown in Tables 3 to 6 . However, significant results
in Tables 3 to 6 would not be affected by the missing values under the assumption that the missing data occurred completely at random. We also conducted further analysis based on the assumption of data not missing at random and our main findings did not change much as is shown in Tables 3 to 6 from the analysis using data missing completely at random. 
